Jessica Fitzpatrick1, Eric S Kerns2, Esther D Kim3,4, Stephen M Sozio4,5, Bernard G Jaar3,4,5,6, Michelle M Estrella7, Larisa G Tereshchenko8, Jose M Monroy-Trujillo5, Rulan S Parekh1,3,5,9, Ghada Bourjeily10. 1. Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada. 2. Lahey Hospital and Medical Center, Burlington, Massachusetts. 3. Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland. 4. Welch Center for Prevention, Epidemiology, and Clinical Research, Baltimore, Maryland. 5. Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland. 6. Nephrology Center of Maryland, Baltimore, Maryland. 7. Kidney Health Research Collaborative, Department of Medicine, University of California, San Francisco, and Department of Medicine, San Francisco VA Health Care System, San Francisco, California. 8. Knight Cardiovascular Institute, Department of Medicine, Oregon Health and Science University, Portland, Oregon. 9. Division of Nephrology, Department of Pediatrics and Medicine, The Hospital for Sick Children, University Health Network and University of Toronto, Toronto, Ontario, Canada. 10. Department of Medicine, The Miriam Hospital, Warren Alpert Medical School of Brown University, Providence, Rhode Island.
Abstract
STUDY OBJECTIVES: Patients with end-stage kidney disease commonly experience sleep disturbances. Sleep disturbance has been inconsistently associated with mortality risk in patients on hemodialysis, but the burden of symptoms from sleep disturbances has emerged as a marker that may shed light on these discrepancies and guide treatment decisions. This study examines whether functional outcomes of sleep are associated with increased risk of intermediary cardiovascular outcomes or mortality among adults initiating hemodialysis. METHODS: In 228 participants enrolled in the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease study, the Functional Outcomes of Sleep Questionnaire-10 (FOSQ-10), which assesses functional outcomes of daytime sleepiness, was administered within 6 months of enrollment. Intermediary cardiovascular outcomes included QT correction (ms), heart rate variance (ms2), left ventricular mass index (g/m2), and left ventricular hypertrophy. The association of FOSQ-10 score with all-cause mortality was examined using proportional hazards regression. RESULTS: Mean age was 55 years, and median body mass index was 28 kg/m2 (interquartile range, 24, 33), with 70% of patients being African Americans. Median FOSQ-10 score was 19.7 (interquartile range, 17.1, 20.0). A 10% lower FOSQ-10 score was associated with increased mortality risk (hazard ratio, 1.09; 95% confidence interval, 1.01-1.18). Lower FOSQ-10 scores were associated with longer QT correction duration and lower heart rate variance but not left ventricular mass index or left ventricular mass index. CONCLUSIONS: In adults initiating dialysis, sleep-related functional impairment is common and is associated with intermediary cardiovascular disease measures and increased mortality risk. Future studies should assess the impact of screening for sleep disturbances in patients with end-stage kidney disease to identify individuals at increased risk for cardiovascular complications and death. CITATION: Fitzpatrick J, Kerns ES, Kim ED, et al. Functional outcomes of sleep predict cardiovascular intermediary outcomes and all-cause mortality in patients on incident hemodialysis. J Clin Sleep Med. 2021;17(8):1707-1715.
STUDY OBJECTIVES: Patients with end-stage kidney disease commonly experience sleep disturbances. Sleep disturbance has been inconsistently associated with mortality risk in patients on hemodialysis, but the burden of symptoms from sleep disturbances has emerged as a marker that may shed light on these discrepancies and guide treatment decisions. This study examines whether functional outcomes of sleep are associated with increased risk of intermediary cardiovascular outcomes or mortality among adults initiating hemodialysis. METHODS: In 228 participants enrolled in the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease study, the Functional Outcomes of Sleep Questionnaire-10 (FOSQ-10), which assesses functional outcomes of daytime sleepiness, was administered within 6 months of enrollment. Intermediary cardiovascular outcomes included QT correction (ms), heart rate variance (ms2), left ventricular mass index (g/m2), and left ventricular hypertrophy. The association of FOSQ-10 score with all-cause mortality was examined using proportional hazards regression. RESULTS: Mean age was 55 years, and median body mass index was 28 kg/m2 (interquartile range, 24, 33), with 70% of patients being African Americans. Median FOSQ-10 score was 19.7 (interquartile range, 17.1, 20.0). A 10% lower FOSQ-10 score was associated with increased mortality risk (hazard ratio, 1.09; 95% confidence interval, 1.01-1.18). Lower FOSQ-10 scores were associated with longer QT correction duration and lower heart rate variance but not left ventricular mass index or left ventricular mass index. CONCLUSIONS: In adults initiating dialysis, sleep-related functional impairment is common and is associated with intermediary cardiovascular disease measures and increased mortality risk. Future studies should assess the impact of screening for sleep disturbances in patients with end-stage kidney disease to identify individuals at increased risk for cardiovascular complications and death. CITATION: Fitzpatrick J, Kerns ES, Kim ED, et al. Functional outcomes of sleep predict cardiovascular intermediary outcomes and all-cause mortality in patients on incident hemodialysis. J Clin Sleep Med. 2021;17(8):1707-1715.
Authors: M H Crawford; S J Bernstein; P C Deedwania; J P DiMarco; K J Ferrick; A Garson; L A Green; H L Greene; M J Silka; P H Stone; C M Tracy; R J Gibbons; J S Alpert; K A Eagle; T J Gardner; G Gregoratos; R O Russell; T H Ryan; S C Smith Journal: J Am Coll Cardiol Date: 1999-09 Impact factor: 24.094
Authors: Patrick J Strollo; Ryan J Soose; Joachim T Maurer; Nico de Vries; Jason Cornelius; Oleg Froymovich; Ronald D Hanson; Tapan A Padhya; David L Steward; M Boyd Gillespie; B Tucker Woodson; Paul H Van de Heyning; Mark G Goetting; Oliver M Vanderveken; Neil Feldman; Lennart Knaack; Kingman P Strohl Journal: N Engl J Med Date: 2014-01-09 Impact factor: 91.245
Authors: Ana C Ricardo; Kristen Knutson; Jinsong Chen; Lawrence J Appel; Lydia Bazzano; Eunice Carmona-Powell; Janet Cohan; Manjula Kurella Tamura; Susan Steigerwalt; John Daryl Thornton; Matthew Weir; Nicolas F Turek; Mahboob Rahman; Eve Van Cauter; James P Lash Journal: J Am Soc Nephrol Date: 2017-09-14 Impact factor: 10.121
Authors: Aviya Lanis; Eric Kerns; Susie L Hu; Margaret H Bublitz; Patricia Risica; Susan Martin; Jeffrey Parker; Richard Millman; Lance D Dworkin; Ghada Bourjeily Journal: Lung Date: 2018-05-26 Impact factor: 2.584
Authors: D S Hui; K W To; F W Ko; J P Fok; M C Chan; J C Ngai; A H Tung; C W Ho; M W Tong; C-C Szeto; C-M Yu Journal: Thorax Date: 2006-08-23 Impact factor: 9.139
Authors: Mark Unruh; Manjula Kurella Tamura; Brett Larive; Anjay Rastogi; Sam James; Brigitte Schiller; Jennifer Gassman; Christopher Chan; Robert Lockridge; Alan Kliger Journal: Am J Nephrol Date: 2011-04-08 Impact factor: 3.754
Authors: Scott B Boyd; Radhika Chigurupati; Joseph E Cillo; Gail Eskes; Reginald Goodday; Tina Meisami; Christopher F Viozzi; Peter Waite; James Wilson Journal: J Oral Maxillofac Surg Date: 2018-08-04 Impact factor: 1.895
Authors: Sarah L Appleton; Andrew Vakulin; Sean A Martin; Carol J Lang; Gary A Wittert; Anne W Taylor; R Doug McEvoy; Nick A Antic; Peter G Catcheside; Robert J Adams Journal: Chest Date: 2016-03-19 Impact factor: 9.410